# Nippon Protein Co., Ltd. Ashikaga Plant - Inspection Records

Source: https://www.keypedia.com/companies/nippon-protein-co-ltd-ashikaga-plant/ccd4e515-8d9e-4f63-9a5d-b117cf2659d6

> Inspection records and compliance data for Nippon Protein Co., Ltd. Ashikaga Plant in Ashikaga, None. Access full analysis and detailed observations.

---

## Details

- Name: Nippon Protein Co., Ltd. Ashikaga Plant
- FEI Number: 3004310658
- City: Ashikaga
- State: None
- Country Name: Japan
- Address Line 1: 575-1, Shimada-Cho
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [483 - Nippon Protein Co., Ltd. Ashikaga Plant - 2025-06-27](https://www.keypedia.com/records/483/nippon-protein-co-ltd-ashikaga-plant/634252ef-80f9-46ea-b6ce-40a925e2f8e3) — source: FDA, date: June 27, 2025
- [FDA Inspection 1274601 - Nippon Protein Co., Ltd. Ashikaga Plant - 2025-06-27](https://www.keypedia.com/records/fda_inspections/nippon-protein-co-ltd-ashikaga-plant/34dcc5b9-ab4b-4337-b9a1-58f7756b37a4) — source: FDA, date: June 27, 2025
- [FDA Inspection 1274601 - Nippon Protein Co., Ltd. Ashikaga Plant - 2025-06-27](https://www.keypedia.com/records/fda_inspections/nippon-protein-co-ltd-ashikaga-plant/81cbc980-d2b7-41da-867f-3c76e9ff08c1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 27, 2025
- [FDA Inspection 1061073 - Nippon Protein Co., Ltd. Ashikaga Plant - 2018-06-22](https://www.keypedia.com/records/fda_inspections/nippon-protein-co-ltd-ashikaga-plant/5738b078-e9a6-4856-9102-053abac634de) — classification: No Action Indicated (NAI), source: FDA, date: June 22, 2018
- [FDA Inspection 951453 - Nippon Protein Co., Ltd. Ashikaga Plant - 2015-11-20](https://www.keypedia.com/records/fda_inspections/nippon-protein-co-ltd-ashikaga-plant/239e55bd-ffcc-43ec-987e-cf0adea167e5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 20, 2015
- [FDA Inspection 702060 - Nippon Protein Co., Ltd. Ashikaga Plant - 2010-11-17](https://www.keypedia.com/records/fda_inspections/nippon-protein-co-ltd-ashikaga-plant/fcddd974-fa2a-4141-b8db-a7f70db60877) — classification: No Action Indicated (NAI), source: FDA, date: November 17, 2010

## Related Companies

- [Cambrex Charles City, Inc.](https://www.keypedia.com/companies/cambrex-charles-city-inc/b14d342b-e5ae-4df6-ad7a-39cd62dfb9c6)
- [Livzon New North River Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-new-north-river-pharmaceutical-co-ltd/49cdcdc8-9c6c-4486-b6cd-e404c21dd2d2)
- [Shandong Xinhua Pharmaceutical Company Limited](https://www.keypedia.com/companies/shandong-xinhua-pharmaceutical-company-limited/7350901d-493e-45cb-a67f-c73093cf762e)
- [Cambrex Karlskoga AB](https://www.keypedia.com/companies/cambrex-karlskoga-ab/c3f2350f-a38e-4e0c-9bac-e94c0255764c)
- [Neuland Laboratories Limited (Unit I)](https://www.keypedia.com/companies/neuland-laboratories-limited-unit-i/2ab72f34-8d5a-4919-8777-83a4fa3cadd5)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/882d7962-58d4-4de8-9d0b-86bf2cf4773e)
- [Olon S.p.A.](https://www.keypedia.com/companies/olon-spa/7e0ac35e-0f38-43f3-8415-015a3d5c0248)
- [Siegfried PharmaChemikalien Minden Gmbh](https://www.keypedia.com/companies/siegfried-pharmachemikalien-minden-gmbh/711ac70f-e753-40c0-92fd-687cb4eeecc2)
- [AstraZeneca Pharmaceuticals, LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/24c4d7fa-217f-4286-8074-011be79e658f)
- [Ajinomoto Co., Inc.](https://www.keypedia.com/companies/ajinomoto-co-inc/0cddfef7-b7e4-499f-81aa-0d5e77d331d4)

## Related Officers

- [Crystal Monroy](https://www.keypedia.com/people/crystal-monroy/b0414886-fb71-4f35-a453-0ad2baf13bfc)